Sentiment-Signal
23,2
Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 22.08.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Section 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appoi |
| 22.04.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Section 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appoi |
| 27.12.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ion 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointme |
| 21.12.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ion 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointme |
| 03.11.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ion 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointme |
| 08.06.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ction 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appoint |
| 20.01.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ction 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointm |
| 10.01.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ction 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointm |
Stammdaten
Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.
Unternehmen & Branche
| Name | CLOVER HEALTH INVESTMENTS, CORP. /DE |
|---|---|
| Ticker | CLOV |
| CIK | 0001801170 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Healthcare Plans |
| SIC | 6324 · Hospital & Medical Service Plans |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 1,30 Mrd. USD |
| Beta | 2,25 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 1,924,308,000 | -85,549,000 | 541,011,000 | ||
| 2025-09-30 | 10-Q | 496,650,000 | -24,377,000 | 559,659,000 | ||
| 2025-06-30 | 10-Q | 477,620,000 | -10,578,000 | 574,987,000 | ||
| 2025-03-31 | 10-Q | 462,331,000 | -1,274,000 | 583,717,000 | ||
| 2024-12-31 | 10-K | 1,371,131,000 | -43,009,000 | 580,742,000 | ||
| 2024-09-30 | 10-Q | 330,986,000 | -9,155,000 | 653,013,000 | ||
| 2024-06-30 | 10-Q | 356,260,000 | 7,408,000 | 674,210,000 | ||
| 2024-03-31 | 10-Q | 346,922,000 | -19,170,000 | 671,770,000 | ||
| 2023-12-31 | 10-K | 1,260,543,000 | -213,361,000 | -0.44 | 570,671,000 | |
| 2023-09-30 | 10-Q | 306,028,000 | -41,469,000 | -0.09 | 684,980,000 | |
| 2023-06-30 | 10-Q | 320,138,000 | -28,814,000 | -0.06 | 702,015,000 | |
| 2023-03-31 | 10-Q | 321,992,000 | -72,606,000 | -0.15 | 737,485,000 | 323,107,000 |
| 2022-12-31 | 10-K | 1,096,552,000 | -339,567,000 | -0.71 | 808,620,000 | 347,738,000 |
| 2022-09-30 | 10-Q | 856,817,000 | -75,489,000 | -0.16 | 1,557,679,000 | 391,980,000 |
| 2022-06-30 | 10-Q | 846,700,000 | -104,362,000 | -0.22 | 2,063,206,000 | 426,922,000 |
| 2022-03-31 | 10-Q | 874,379,000 | -75,490,000 | -0.16 | 2,679,894,000 | 489,813,000 |
| 2021-12-31 | 10-K | 1,471,996,000 | -587,756,000 | -1.42 | 950,804,000 | 535,414,000 |
| 2021-09-30 | 10-Q | 427,163,000 | -34,527,000 | -0.08 | 952,478,000 | 408,387,000 |
| 2021-06-30 | 10-Q | 412,472,000 | -317,611,000 | -0.78 | 1,215,897,000 | 310,952,000 |
| 2021-03-31 | 10-Q | 200,325,000 | -48,417,000 | -0.13 | 866,942,000 | 585,032,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-18 | Reynoso Jamie L. | Officer, CEO, Medicare Advantage | Open Market Sale | -5,833 | 1.91 | -11,141.03 | -8,8% | |
| 2026-03-04 | Priest Brady Patrick | Officer, CEO of Home Care | Open Market Sale | -175,000 | 2.17 | -379,750.00 | -299,0% | |
| 2026-01-20 | Reynoso Jamie L. | Officer, CEO, Medicare Advantage | Open Market Sale | -4,597 | 2.58 | -11,860.26 | -9,3% | |
| 2026-01-07 | Reynoso Jamie L. | Officer, CEO, Medicare Advantage | Open Market Sale | -2,102 | 2.53 | -5,318.06 | -4,2% | |
| 2025-12-18 | Reynoso Jamie L. | Officer, CEO, Medicare Advantage | Open Market Sale | -4,913 | 2.61 | -12,822.93 | -10,1% | |
| 2025-11-04 | Reynoso Jamie L. | Officer, CEO, Medicare Advantage | Open Market Sale | -30,385 | 3.58 | -108,778.30 | -85,7% | |
| 2025-10-17 | Reynoso Jamie L. | Officer, CEO, Medicare Advantage | Open Market Sale | -16,514 | 2.69 | -44,422.66 | -35,0% | |
| 2025-10-07 | Reynoso Jamie L. | Officer, CEO, Medicare Advantage | Open Market Sale | -2,012 | 2.65 | -5,331.80 | -4,2% | |
| 2025-09-17 | Reynoso Jamie L. | Officer, CEO, Medicare Advantage | Open Market Sale | -4,914 | 3.09 | -15,184.26 | -12,0% | |
| 2025-08-13 | Loengard Anna U | Director | Open Market Purchase | 14,500 | 2.59 | 37,555.00 | +29,6% | |
| 2025-08-13 | Loengard Anna U | Director | Open Market Purchase | 12,000 | 2.60 | 31,200.00 | +24,6% | |
| 2025-08-08 | Garipalli Vivek | Director, 10% Owner | Open Market Purchase | 31,980 | 2.17 | 69,396.60 | +54,6% | |
| 2025-08-07 | Garipalli Vivek | Director, 10% Owner | Open Market Purchase | 415,000 | 2.24 | 929,600.00 | +732,0% | |
| 2025-08-04 | Reynoso Jamie L. | Officer, CEO, Medicare Advantage | Open Market Sale | -6,823 | 2.89 | -19,718.47 | -15,5% | |
| 2025-07-23 | Wai Conrad | Officer, CEO, Counterpart Health | Open Market Sale | -91,197 | 3.32 | -302,774.04 | -238,4% | |
| 2025-07-22 | Wai Conrad | Officer, CEO, Counterpart Health | Open Market Sale | -118,600 | 3.29 | -390,194.00 | -307,3% | |
| 2025-07-08 | Wai Conrad | Officer, CEO, Counterpart Health | Open Market Sale | -15,203 | 3.26 | -49,561.78 | -39,0% | |
| 2025-07-07 | Reynoso Jamie L. | Officer, CEO, Medicare Advantage | Open Market Sale | -2,012 | 2.85 | -5,734.20 | -4,5% | |
| 2025-07-03 | Reynoso Jamie L. | Officer, CEO, Medicare Advantage | Open Market Sale | -19,789 | 2.58 | -51,055.62 | -40,2% | |
| 2025-06-17 | Reynoso Jamie L. | Officer, CEO, Medicare Advantage | Open Market Sale | -20,450 | 2.86 | -58,487.00 | -46,1% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.